Roche’s Accu-Chek Connect Diabetes Management App has hit yet another snag with the FDA. On February 15, the agency issued a Class 2 Device Recall for certain software versions of the app due to a bug that could lead users to self-administer inappropriate doses of insulin.

from MobiHealthNews http://ift.tt/2oeOBiF

Related Posts:

0 comments:

Post a Comment

Popular Posts